Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
HDA Convenes Supply Chain Experts and Patient Advocates To Examine Drug Shortages Solutions
HDA recently hosted a LinkedIn Live discussion exploring how supply chain stakeholders are working together to tackle these challenges and advocate for solutions. The event featured perspectives from Laura Bray, Chief Change Maker and Founder of Angels for Change, and April Giles, Executive Director of the End Drug Shortages Alliance (EDSA). Chip Davis, HDA President and Chief Executive Officer, moderated the discussion, which also touched upon effects of recent hurricanes on the prescription supply and the newly announced Biden Cancer Moonshot pilot program to curb pediatric shortages.
Read three takeaways from the conversation.
Debating the Key Issues Shaping the Future of Healthcare
HDA served as a sponsor and participant in the The Hill's recent "Future of Health Care Summit." The event brought together leading healthcare experts to discuss the most critical issues shaping an evolving healthcare landscape, including advancements in patient access to care, the pursuit of health equity and the importance of resetting the care delivery model across the United States.
The summit featured a conversation between HDA’s Dr. Nicolette Louissaint, Senior Vice President of Policy & Strategic Planning, and Sarah Wells Kocsis, Director of the Milken Institute’s Center for Public Health. This blog contains key takeaways from the summit.
Healthcare Distributors Are Improving Health Equity and Supporting Patients in Need
On October 7, we launched a three-part series to showcase how the distribution industry is making a difference in local communities across the country. In part one, we explored how HDA’s distributor members are leaving their imprint upon communities through corporate, foundation and employee support.
HDA To Host Traceability Seminar in August
The Healthcare Distribution Alliance (HDA) will host its annual Traceability Seminar two months early, on August 29–31, 2023, in Washington, D.C. The earlier date reflects the urgency surrounding the upcoming Drug Supply Chain Security Act (DSCSA) implementation deadline and the critical need to share information and solutions.